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COMMUNICATION 
A fluorine-18 radiolabelling method enabled by rhenium(I) 
complexation circumvents the requirement of anhydrous 
conditions 
Mitchell A. Klenner[a,b], Giancarlo Pascali*[a,c], Bo Zhang[a,d], Tiffany R. Sia[a,c], Lawson K. Spare[e], 
Anwen M. Krause-Heuer[a], Janice R. Aldrich-Wright[e], Ivan Greguric[a], Adam Guastella[c], 
Massimiliano Massi[b] and Benjamin H. Fraser*[a] 
Abstract: Azeotropic distillation is typically required to achieve 
fluorine-18 radiolabelling during the production of positron emission 
tomography (PET) imaging agents. However, this time consuming 
process also limits fluorine-18 incorporation, due to radioactive 
decay of the isotope and its adsorption to the drying vessel. In 
addressing these limitations, we herein report the fluorine-18 
radiolabelling of one model rhenium(I) complex, which is significantly 
improved under conditions that do not require azeotropic drying. This 
work could open towards the investigation of a simplified metal-
mediated late stage radiofluorination method, which would expand 
upon the accessibility of new PET and PET-optical probes. 
Main Text: 
Positron emission tomography (PET) plays an important clinical 
role towards unveiling the underlying biochemistry of diseases 
via the administration of positron (β+) emitting 
radiopharmaceuticals. Radiosynthesis of most PET tracers 
needs to be performed quickly, in order to obtain a large enough 
dose for a successful PET imaging experiment, due to the 
radioactive decay of the β+ emitting isotope. Therefore the 
production of PET radiotracers is performed using automated 
synthesis modules, and many research groups have worked 
towards integrating microfluidic technologies to reduce radiation 
dose, miniaturise the workspace and improve production.[1] 
Fluorine-18 is the most commonly employed PET radioisotope, 
owing to its 97% β+ decay profile, ideal 109.7 min half-life and 
low 0.64 MeV β+ energy.[2] However, one drawback is that 
fluorine-18 is generally produced by the cyclotron mediated 
18O(p,n)18F reaction on oxygen-18 enriched water, which affords 
[18F]fluoride in an aqueous environment, that is typically 
unreactive towards nucleophilic substitution; nonetheless, the 
interest in employing this unfavorable aqueous environment has 
inspired some innovative approaches. [3] Traditionally, in order to 
provide an anhydrous environment, the [18F]fluoride in water is 
trapped on an anion exchange resin (thus also removing 
radioactive cationic impurities), eluted with a complexing agent 
in aqueous/organic solvent mixture, and azeotropically dried in a 
distillation vial. This azeotropic drying is an inefficient and time 
consuming process (>15 mins[4]) during which period, 
radioactivity (≥10%) is lost due to the radioactive decay of the 
fluorine-18 isotope, as well as non-specific adsorption of 
[18F]fluoride to the surface of the distillation vial, leading to lower 
radiochemical yield (RCY) of the PET radiotracer.[3,5] 
Scheme 1. Synthesis of radiolabelling precursors 3 and 5, and non-radioactive 
standards 4 and 6. Refer to SI sections 1.1 - 1.5 for detailed procedures. 
Having been inspired by recent efforts to couple PET imaging 
with an optical tracer to complement disease diagnosis [6], and 
given our experience in the use of phosphorescent rhenium(I) 
tricarbonyl diimine systems as optical markers for live cell 
imaging and diagnosis of pathologies[7], we sought to investigate 
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the fluorine-18 radiolabelling of this class of rhenium complexes 
as potential precursors for the future development of PET-optical 
multimodal markers. Scheme 1 shows the synthetic route used 
to synthesise the ligand (3) and complex (5) precursors, as well 
as the non-radioactive standards 4 and 6. N-Oxidation of 1,10-
phenanthroline allowed for selective chlorination in the 2- 
position by the Vilsmeier reagent to afford 3. Nucleophilic 
aromatic substitution with azeotropically dried fluoride, using 18-
crown-6 as a phase transfer catalyst, then afforded the novel 2-
fluoro-1,10-phenanthroline ligand (4). Ligands 3 and 4 were then 
chelated to a Re(I) metal centre to attain complexes 5 and 6, 








Figure 1. Simplified schematic of the flow chemistry configuration assembled 







Figure 2. Temperature dependence of nucleophilic aromatic substitution of 
ligand 3 with [18F]fluoride under azeotropically dried (red crosses) and non-
azeotropically dried (blue squares) conditions. 
The radiosyntheses of [18F]4 and [18F]6, from 3 and 5 precursors 
respectively, were automated via a flow chemistry set-up 
adapted from our previous work[8] as shown in Figure 1. Within 
this set-up, aqueous [18F]fluoride was first passed through an 
MP1 cartridge and eluted with tetraethylammonium bicarbonate 
(TEA+HCO3
–) in 90% CH3CN:H2O solution. The resulting 
[18F]TEA+F– complex was then either azeotropically dried (dry 
conditions) or not azeotropically dried (wet conditions), before 
being loaded into the microreactor alongside the desired 
precursor solution (3 or 5). 
The RCYs obtained for the radiosynthesis of [18F]4 from 3 under 
varying temperature conditions are illustrated in Figure 2. These 
conditions employed the same residence times (47 s) and 
precursor amounts (0.08 - 0.12 µmol) within the microreactor. 
Under traditional dry conditions, the RCY of ligand [18F]4 
followed the expected trend, whereupon the yield increases as a 
function of temperature.[8] In this instance, [18F]4 only formed at 
temperatures greater than 130°C, providing a maximum RCY of 
61% at 190°C. The radiosynthesis of complex [18F]6 from 5 was 
then attempted under analogous dry conditions, and the 







Figure 3. Temperature dependence of nucleophilic aromatic substitution of 
complex 5 with [18F]fluoride under azeotropically dried (red crosses, dry) and 
not azeotropically dried (blue squares, wet) conditions. 
Intriguingly, in this case we observed an opposite trend to the 
ligand, whereupon the complex [18F]6 only formed at 
temperatures below 150°C (in contrast to the ligand [18F]4 which 
required higher temperatures to afford a radioproduct). The 
RCYs for the complex [18F]6 were also noticeably lower than that 
of the ligand [18F]4, with a maximum of 19% RCY obtained at 
30°C; in addition, it was clearly noticeable the appearance of a 
UV-absorbing degradation product (Figure 4). We suspected 
that this by-product could be due to base-mediated degradation 
of 5, and we indeed verified this by analyzing in HPLC a DMSO 
solution of 5 spiked with 5 µL of 5N NaOH. Therefore, we sought 
to suppress this undesired process by modifying the basicity of 
the reaction media. Thus, the radiosynthesis of [18F]6 was 
performed under wet conditions, whereupon azeotropic drying 
was excluded while preparing the radiofluorinating solution, 





which realized a 10% v/v content of H2O. Such wet conditions 
have been shown previously to be influential in the formation of 
different reaction products[9] or improved RCYs; to our delight, 
the radiosynthesis of [18F]6 under wet conditions was successful 
and we achieved as large as 78% RCY at a temperature as low 
as 50°C. Residence times and precursor amounts were also 
optimized in order to maximize the RCY (refer to SI 3.1), yielding 
[18F]6 in as high as 87% RCY when using 0.38 µmol of precursor  
within a residence time of 47 s. Significantly less of the 
degradation product from 5 was observed under these wet and 
low temperature conditions, confirming the desired switch from 
degradation to improved nucleophilic displacement by 
[18F]fluoride in these aqueous conditions. To verify that the Re(I) 
centre was influential in facilitating nucleophilic substitution in 
the 2- position in such extremely mild conditions, we also 
performed the radiosynthesis of the ligand [18F]4 under identical 
wet conditions which, as expected, afforded no radioproduct at 
all as shown in Figure 2. It is suspected that the electron 
withdrawing nature of the Re(I) metal centre, due to the π-
acceptance of the CO ligands, may activate the 2-position of 
phenanthroline for improved nucleophilic substitution at low 
temperatures. Mechanistic studies are currently underway in our 
labs to explain why the presence of water favors the 









Figure 4. UV absorbance (254nm, solid blue) and superimposed radioactive 
(dashed red) profiles, for dry and wet analogous conditions (top and bottom, 
respectively). UV active degradation by-product (Rt: 3 min) is reduced under 
wet conditions. Rt: [18F]F− (RAD, 1 min), [18F]6 (RAD, 3.7 min) 5 (UV, 6.2 min). 
The direct radiolabelling of the Re(I) tricarbonyl diimine complex 
was also compared to a two-step automated radiosynthetic 
process.[10] Using microfluidic technology, we assembled a 
second microreactor in series, alongside a fourth pump to supply 
the Re(CO)5Cl precursor, as shown in Figure 5. RCYs as great 
as 35% were able to be achieved using ≥ 5× stoichiometric 
equivalents of Re(CO)5Cl compared to 3, as shown in Figure 6, 
despite the residual basic conditions from the reaction in the first 
microreactor. Therefore, this unprecedented two-step 
microfluidic approach indeed led to the desired final product by 
marginally increasing total process time (4 vs. 10 min), but 
provided a reduced RCY compared to the direct milder 
radiofluorination of 5. A process involving the purification of 
[18F]4 and performance of a separate 2nd step reaction was not 
attempted, as it would have involved a much longer and more 





Figure 5. Simplified schematic of the flow chemistry configuration assembled 
for the automated two-step radiosynthesis of [18F]6.  
Before performing the radiolabelling using microfluidic systems, 
we were unable to synthesize 6 from 5 using the usual heated 
and anhydrous conditions which afforded 4 from 3. Given the 
resulting formation of [18F]6 from 5 under wet, low temperature 
conditions, we revisited the bulk non-radioactive synthesis and 
attempted the reaction of 5 to 6 under analogous conditions. UV 
reaction monitoring revealed that complex 6 did indeed form 
under these wet and low temperature conditions (32% HPLC 
conversion) thus demonstrating how fast and efficient 
microfluidic optimization can be also used to identify the best 







Figure 6. Temperature dependence (2nd step) of the two-step radiofluorination 
to form complex [18F]6 under azeotropically dried conditions using one (blue 
squares), five (green circle) and eight (red crosses) stoichiometric equivalents 
of the Re(CO)5Cl precursor. 





Photophysical properties of 6 were also assessed, in order to 
investigate the effect of replacing a chloro for a fluoro substituent 
in the 2- position of phenanthroline, given our initial research 
incentives to develop PET-optical probes. We therefore verified 
that these Re(I) complexes afforded similar quantum yields (Φ = 
0.3%), lifetimes (τ = 27 - 41 ns), emission maxima (λex = 410 
nm, λem = 653 - 654 nm) and monoexponential decay profiles in 
DMSO (SI 4.1 - 4.3). 
In summary, the fluorine-18 radiolabelling of a ligand complexed 
to Re(I) was found to afford optimal RCYs under remarkably 
mild conditions, without the need for azeotropic distillation and 
with a reduction of >100°C for the optimal temperature. Further 
investigations will clarify the involvement of the Re(I) centre in 
the radiofluorination mechanism, and will seek to apply this 
radiolabelling strategy toward improving the RCY of existing 
PET tracers, as well as toward accessing new PET and PET-
optical probes. 
Experimental Section 
Aqueous [18F]fluoride was produced on an IBA Cyclone 18 Twin 
cyclotron (ANSTO, Camperdown, Australia) using the 18O(p,n)18F nuclear 
reaction. Microfluidic radiosyntheses were performed in Discovery Mode 
using a NanoTek LF Microfluidic Synthesis System (Advion, Ithaca, NY) 
connected to a standard laptop using the NanoTek software, V1.4.0 GMP 
Lite. Microreactors were made of fused silica tubing (100 µm × 2 m), 
coiled tightly into a brass ring containing a thermoresistent polymer to 
hold the tubing in place. RadioHPLC analyses were carried out using a 
Shimadzu system comprised of a CBM-20 controller, LC-20AD pump, 
SIL-20AHT autoinjector, SPD-M20A PDA detector (for UV analyses) and 
a Lablogic Posi-RAM gamma detector. Analyses were performed using 
isocratic conditions consisting of CH3CN/H2O/TFA mobile phases 
(7.95:91.95:0.10% v/v for [18F]4 and 64.95:34.95:0.10% v/v for [18F]6), on 
a Chromolith RP column (monolith system, Merck, 50 × 4.6 mm). RCYs 
were calculated using the radio-HPLC profiles, integrating the 
radioproduct peak against all the other radioactive peaks (inclusive of the 
unreacted [18F]fluoride), using Laura V4.1.70 SP2 HPLC data analysis 
software. 
 
The microfluidic experiments were carried out on the scale of 29±10 MBq, 
and afforded [18F]6 with a molar activity of 71±12 MBq.nmol-1. 
Experimental details concerning the general syntheses, structure 
elucidation, radiochemistry and photophysical characterisations of the 
reported compounds can be found within the SI sections 5.1 – 5.3. 
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A novel fluorine-18 radiolabelling 
method has been found to circumvent 
the need for preliminary azeotropic 
distillation. The method involves 
complexation to a rhenium(I) centre, 
and is of particular importance in the 
expanded scope of positron emission 
tomography (PET) imaging agent 
design. Results were verified through 
the monitoring of multiple reaction 
conditions by employing microfluidic 
technologies in flow. 
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